Medical Cannabis
- Generic Name
- Medical Cannabis
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- FTS5RM302N
- Background
The use of the plant species Cannabis sativa and Cannabis indica, popularly known as marijuana, has gained popularity in recent years for the management of a wide variety of medical conditions as a wave of legalization in North America has changed public and medical opinion on its use. Consequently, an expanding body of evidence has begun to emerge that has ...
- Associated Conditions
- -
- Associated Therapies
- -
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
- Conditions
- Interventions
- First Posted Date
- 2013-10-17
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 261
- Registration Number
- NCT01964404
- Locations
- 🇺🇸
University of Vermont, Burlington, Vermont, United States
🇺🇸Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation
- First Posted Date
- 2013-02-25
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 26
- Registration Number
- NCT01798186
- Locations
- 🇺🇸
Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States
Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease
- First Posted Date
- 2013-01-18
- Last Posted Date
- 2020-08-18
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 27
- Registration Number
- NCT01771731
- Locations
- 🇺🇸
San Francisco General Hospital, San Francisco, California, United States
Effects of Vaporized Marijuana on Neuropathic Pain
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 44
- Registration Number
- NCT01037088
- Locations
- 🇺🇸
CTSC Clinical Research Center, Sacramento VA Medical Center, Sacramento, California, United States
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
- Conditions
- Interventions
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2021-07-12
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT00946348
- Locations
- 🇺🇸
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy
- First Posted Date
- 2008-10-28
- Last Posted Date
- 2013-07-30
- Lead Sponsor
- Center for Medicinal Cannabis Research
- Target Recruit Count
- 17
- Registration Number
- NCT00781001
- Locations
- 🇺🇸
UC San Diego, Hillcrest Medical Center, San Diego, California, United States
Effect of Quetiapine on Marijuana Withdrawal and Relapse
- Conditions
- Interventions
- First Posted Date
- 2008-08-28
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 20
- Registration Number
- NCT00743366
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse
- Conditions
- Interventions
- First Posted Date
- 2006-09-08
- Last Posted Date
- 2013-02-05
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 8
- Registration Number
- NCT00373503
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Effect of Baclofen on Marijuana Withdrawal and Relapse
- Conditions
- Interventions
- First Posted Date
- 2006-09-08
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 13
- Registration Number
- NCT00373295
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Opioid and Cannabinoid Pharmacokinetic Interactions
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2016-12-09
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 24
- Registration Number
- NCT00308555
- Locations
- 🇺🇸
Community Consortium, San Francisco, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.